The above chart presents the market trend analysis for mayne pharma ltd. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 3 transactions, with a transaction quantity of 23 and a transaction weight of 18.
YearTransactionsQuantityWeight
202422340078124
202532318
Bill of lading data
<
1/15
>
Trade date
2025/11/12
B/L No.
——
Suppliers
mayne pharma ltd.
Buyers
laxai life sciences pvt ltd.
Product description
OTROS COMPUESTOS HETEROCICLICOS CON HETEROATOMOS DE NITROGENO EXCLUSIVAMENTE NIRAPARIB IMPURITY A REFERENCE MARCA MAYNE PHARMA
Expand
Product description
OTROS COMPUESTOS HETEROCICLICOS CON HETEROATOMOS DE NITROGENO EXCLUSIVAMENTE NIRAPARIB REFERENCE STANDARD BATCH MARCA MAYNE PHARMA
Expand
mayne pharma ltd. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as pharmaceutical,medicament,astrix.
According to the 52wmb.com global trade database, as of 2025-11-12, the company has completed 470 international trades,
with its main trading regions covering sri lanka,russia,united states etc.
The core products include HS30049090,HS300490,HS300449 etc,
often transported via melbourne,port brisbane, port tauranga etc,
and its main trading partners are akbar pharmaceutical pvt ltd.,sunshine heathcare lanka ltd.,dr reddy s laborotoies inc..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on mayne pharma ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.